Epidemiologie - France Portal | Health Databases

Home

Catalogue

Catalogue
ARCHIVES

Covid-19

Resources

Lexicon
Legal notices

Useful links

General links
Covid-19 links

Login in to your account

Email address Password

You do not have an account yet ? Sign up !

You have forgotten your password ?

Portail Epidémiologique

ITMO public health Aviesan

Aviesan

Archives

Search with one or more keywords

All records French records only English records only

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml

Export to XML

Please choose the format :

pdf

Export to PDF

Which version do you want to export ?

Download full content

Download light content

csv

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

ARCHIVES : 309 forms

Sorting of results :

EPIMAN-II-Mille - Longitudinal Study on Hospitalised Patients with Acute Mania Pertaining to Primary Bipolar Disorder

Head : Hantouche Elie, Centre de l’Humeur, département de psychiatrie adulte, hôpital Pitié-Salpêtrière
Azorin Jean-Michel

Version 3

103

Last update : 09/05/2017

ARCHIVE

EPIMAN-II-Mille - Longitudinal Study on Hospitalised Patients with Acute Mania Pertaining to Primary Bipolar Disorder

Head : Hantouche Elie, Centre de l’Humeur, département de psychiatrie adulte, hôpital Pitié-Salpêtrière
Azorin Jean-Michel

Main objective

To demonstrate the influence of temperament on the expression of mania; particularly the link between mixed mania and depressive temperament.

Inclusion criteria

- male and female
- adult
- hospitalised and presenting with acute mania pertaining to primary bipolar disorder

Last update : 09/05/2017

I-NORM - Management by French General Practitioners of uncontrolled hypertensive patients treated by dual therapy

Head : Herrmann Marie-Annick, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Version 1

104

Last update : 01/01/2018

ARCHIVE

I-NORM - Management by French General Practitioners of uncontrolled hypertensive patients treated by dual therapy

Head : Herrmann Marie-Annick, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Main objective

Describe medical strategies used by general practitioners for uncontrolled hypertension despite dual-therapy: the I-NORM survey

Inclusion criteria

Register: Patient>=18 years, seen in routine consultation, monitored for HBP, known for more than 3 months, treated via fixed or free dual therapy for his HBP, dual therapy initiated by the participating doctor or the corresponding specialist.
Study: pt from the register, uncontrolled HBP (SBP >=140 mmhg and /or DBP>=90mmhg all comer pt or SBP >=130 mmhg and /or DBP>=80mmhg diabetic pt or with kidney failure), not participating into a clinical trial

Last update : 01/01/2018

MANIF-2000 FOLLOWED BY MANIF-2 - Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France

Head : Carrieri Maria-Patrizia, ORS PACA - INSERM U912
Obadia Yolande, ORS PACA

Version 3

105

Last update : 09/05/2017

ARCHIVE

MANIF-2000 FOLLOWED BY MANIF-2 - Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France

Head : Carrieri Maria-Patrizia, ORS PACA - INSERM U912
Obadia Yolande, ORS PACA

Main objective

General objective: MANIF 2000 is a cohort of HIV-1 seropositive patients that have been infected through intravenous drug use. Patients should have an initial CD4 count of > 300/mm3. The initial aim of this study was to compare HIV progression according to whether patients were still active addicts, substituting or sober. This goal was revised in light of the changes in HIV history with the release of highly active combination therapy and the treatment of addicts with buprenorphine substitution. MANIF 2000 has become an observational cohort study focused on risk-related sexual behaviours associated with drug addiction, as well as adherence to therapy and interaction between substitution and treatment. Secondary objectives: - To determine the impact of depression and HIV treatment adherence on clinical progression; - to determine the impact of retention in substitution treatment on virological success.

Inclusion criteria

HIV-1 or HIV-2 seropositive patients that have been infected through intravenous drug use with an initial CD4 count greater than 300/mm3 and at clinical stage A or B.

Last update : 09/05/2017

Young-Thyr - Risk Factors of Differentiated Thyroid Cancer in Young Patients in Eastern France: A Case-Control Study

Head : De Vathaire Florent, Equipe 3 Épidémiologie des cancers : radiocarcinogenèse et effets iatrogènes des traitements UMR 1018 Center for research in epidemiology and population health (CESP)

Version 1

106

Last update : 01/01/2020

ARCHIVE

Young-Thyr - Risk Factors of Differentiated Thyroid Cancer in Young Patients in Eastern France: A Case-Control Study

Head : De Vathaire Florent, Equipe 3 Épidémiologie des cancers : radiocarcinogenèse et effets iatrogènes des traitements UMR 1018 Center for research in epidemiology and population health (CESP)

Main objective

To highlight genetic and environmental factors that contribute to the onset of differentiated thyroid cancer in children and young adults. To study the potential consequences of the Chernobyl accident.

Inclusion criteria

- Men or women - residing in Eastern France

Last update : 01/01/2020

SPRIK - General practitioner/paediatrician-based surveillance to estimate the disease burden of rotavirus gastroenteritis in children <5 years of age in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

107

Last update : 01/01/2018

ARCHIVE

SPRIK - General practitioner/paediatrician-based surveillance to estimate the disease burden of rotavirus gastroenteritis in children <5 years of age in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Estimate the incidence of RVGE leading to a consultation of a general practitioner or pediatrician in a monitored population of children under the age of 5 years.

Inclusion criteria

• Any child under the age of 5 years from the monitored population who spontaneously consults an investigating center for a acute gastroenteritis

Last update : 01/01/2018

LAPS - Female patients with breast cancer treated with lapatinib in the context of an expanded access program (ATU): description of the care trajectory and clinical course

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

108

Last update : 01/01/2020

ARCHIVE

LAPS - Female patients with breast cancer treated with lapatinib in the context of an expanded access program (ATU): description of the care trajectory and clinical course

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Describe the care pathways of patients with breast cancer who have received and/or are receiving treatment with lapatinib under Temporary Use Authorization (TUA)

Inclusion criteria

Patient who has received lapatinib for the treatment of breast cancer within the framework of a TUA between January 1, 2007 and 3 months prior to the beginning of the study

Last update : 01/01/2020

Previous
1
...
12
13
14
15
16
17
18
19
20
21
22
23
24
...
52
Next

Please wait...

ABOUT

Help about your workspace

CATALOG

RESOURCES

USEFUL LINKS

This site complies with the HONcode standard for trustworthy health information:
verify here.

8 rue de la Croix Jarry

75013 Paris

Phone : +33 1 44 23 67 47

portail-epidemiologie@inserm.fr

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

XXX

View Edit Create here